CRYO CELL INTERNATIONAL INC

For the period ended Aug 31, 2024. Filed Oct 15, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Aug 31, 2024 · Filed Oct 15, 2024

CCEL$4.87-0.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Stockholders’ Deficit

Additional · Total
Common Stock · Paid-In · Treasury · Accumulated · Stockholders'
Shares · Amount · Capital · Stock · Deficit · Deficit
Balance at May 31, 2024	14,849,246	$148,492		$43,896,637		$(24,839,156)	$(29,947,151)		$(10,741,178)
Exercise of stock options	373	4		998				1,002
Compensatory element of stock options			145,941				$145,941
Treasury stock					(16,400)		(16,400)
Net income						1,051,679	$1,051,679
Balance at August 31, 2024	14,849,619	$148,496		$44,043,576		$(24,855,556)	$(28,895,472)		$(9,558,956)
Additional · Total
Common Stock · Paid-In · Treasury · Accumulated · Stockholders'
Shares · Amount · Capital · Stock · Deficit · Deficit
Balance at November 30, 2023	14,849,246	$148,492		$43,411,143		$(23,431,685)	$(31,159,182)		$(11,031,232)
Exercise of stock options	373	4		998				1,002
Compensatory element of stock options			631,435				631,435
Treasury stock					(1,423,871)		(1,423,871)
Net income						2,263,710	2,263,710
Balance at August 31, 2024	14,849,619	$148,496		$44,043,576		$(24,855,556)	$(28,895,472)		$(9,558,956)
Additional · Total
Common Stock · Paid-In · Treasury · Accumulated · Stockholders'
Shares · Amount · Capital · Stock · Deficit · Deficit
Balance at May 31, 2023	14,848,001	$148,480		$43,066,971		$(23,424,101)	$(20,649,725)		$(858,375)
Exercise of stock options	1,245	12		(2,876)				(2,864)
Compensatory element of stock options			172,099				172,099
Treasury stock					(7,584)		(7,584)
Net income						680,561	680,561
Balance at August 31, 2023	14,849,246	$148,492		$43,236,194		$(23,431,685)	$(19,969,164)		$(16,163)
Additional · Total
Common Stock · Paid-In · Treasury · Accumulated · Stockholders'
Shares · Amount · Capital · Stock · Deficit · Deficit
Balance at November 30, 2022	14,848,001	$148,480		$42,597,380		$(22,632,649)	$(21,637,513)		$(1,524,302)
Exercise of stock options	1,245	12		(2,876)				(2,864)
Compensatory element of stock options			641,690				641,690
Treasury stock					(799,036)		(799,036)
Net income						1,668,349	1,668,349
Balance at August 31, 2023	14,849,246	$148,492		$43,236,194		$(23,431,685)	$(19,969,164)		$(16,163)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.